Wellington Management Group LLP Increases Stock Position in Liquidia Technologies, Inc. $LQDA

Key Points

• Wellington Management Group LLP increased its stake in Liquidia Technologies by 9.0%, holding 196,226 shares worth approximately $2.89 million as of the most recent SEC filing.
• On the analyst front, Liquidia Technologies received varied ratings, with Oppenheimer setting a price target of $13.00 and Needham boosting its target to $36.00, while the overall consensus rating is "Buy" with a target price of $32.11.
• Insider transactions revealed that both CEO Roger Jeffs and insider Jason Adair sold shares on July 14th, reducing their ownership stakes by 1.91% and 1.31%, respectively.

Wellington Management Group LLP raised its stake in Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report) by 9.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 196,226 shares of the company's stock after buying an additional 16,227 shares during the quarter. Wellington Management Group LLP owned about 0.23% of Liquidia Technologies worth $2,894,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in LQDA. Kovitz Investment Group Partners LLC acquired a new position in Liquidia Technologies in the 1st quarter valued at about $384,000. Nuveen LLC purchased a new position in shares of Liquidia Technologies in the first quarter valued at approximately $2,642,000. Aigen Investment Management LP acquired a new position in shares of Liquidia Technologies in the first quarter valued at approximately $151,000. CenterBook Partners LP purchased a new stake in Liquidia Technologies during the 1st quarter worth approximately $1,786,000. Finally, Hurley Capital LLC acquired a new stake in Liquidia Technologies during the 1st quarter worth approximately $32,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Liquidia Technologies news, insider Jason Adair sold 26,057 shares of the company's stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of $27.86, for a total transaction of $725,948.02. Following the transaction, the insider directly owned 171,029 shares in the company, valued at approximately $4,764,867.94. This represents a 13.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Michael Kaseta sold 30,000 shares of the firm's stock in a transaction on Tuesday, August 5th. The shares were sold at an average price of $20.00, for a total value of $600,000.00. Following the completion of the transaction, the chief financial officer owned 376,412 shares of the company's stock, valued at approximately $7,528,240. This represents a 7.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold 828,073 shares of company stock worth $22,294,240 over the last quarter. 30.10% of the stock is owned by insiders.

Liquidia Technologies Stock Up 1.8%

Shares of Liquidia Technologies stock traded up $0.50 during trading hours on Wednesday, hitting $29.08. The company had a trading volume of 2,078,870 shares, compared to its average volume of 1,819,298. The company has a debt-to-equity ratio of 9.84, a current ratio of 2.49 and a quick ratio of 2.41. The company's 50-day moving average is $19.48 and its two-hundred day moving average is $16.52. The company has a market cap of $2.50 billion, a P/E ratio of -17.05 and a beta of 0.22. Liquidia Technologies, Inc. has a twelve month low of $8.75 and a twelve month high of $29.94.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The company had revenue of $8.84 million during the quarter, compared to analysts' expectations of $3.90 million. Liquidia Technologies's revenue was up 141.5% compared to the same quarter last year. Analysts anticipate that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on LQDA shares. Wells Fargo & Company lifted their target price on Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a report on Wednesday, August 13th. Wall Street Zen raised Liquidia Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Scotiabank upped their target price on shares of Liquidia Technologies from $36.00 to $37.00 and gave the stock a "sector outperform" rating in a research note on Wednesday, May 28th. BTIG Research reiterated a "buy" rating on shares of Liquidia Technologies in a research note on Tuesday, May 27th. Finally, Needham & Company LLC increased their price objective on shares of Liquidia Technologies from $32.00 to $36.00 and gave the company a "buy" rating in a research report on Tuesday, August 12th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Liquidia Technologies presently has a consensus rating of "Buy" and an average price target of $32.11.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).